Table 2 Multivariate Cox regression model stratified by treatment for the variables used by composite risk score assessment.

From: Composite risk and benefit from adjuvant dose-dense chemotherapy in hormone receptor-positive breast cancer

 

Log (HR)

HR

95% CI

P value

Age

<35

0.425

1.53

0.72–3.24

0.268

35–39

0.859

2.36

1.39–3.99

0.001

40–44

0.113

1.12

0.68–1.84

0.665

45–49

0.000

1.00

Ref.

 

≥50

0.322

1.38

0.94–2.03

0.100

Nodes

1–3

0.000

1.00

Ref.

 

≥4

0.737

2.09

1.61–2.71

<0.001

Tumor size

≤2

0.000

1.00

Ref.

 

>2

0.577

1.78

1.36–2.34

<0.001

ER (%)

<50

0.262

1.30

0.92–1.82

0.135

≥50

0.000

1.00

Ref.

 

PGR (%)

<20

0.293

1.34

0.96–1.86

0.083

20–49

0.140

1.15

0.82–1.62

0.418

≥50

0.000

1.00

Ref.

 

Histological grade

G1

0.000

1.00

Ref.

 

G2

1.022

2.78

1.13–6.80

0.026

G3

1.092

2.98

1.20–7.40

0.018

Ki-67 (%)

<14

0.000

1.00

Ref.

 

14–19

0.166

1.18

0.75–1.85

0.483

20–25

0.068

1.07

0.72–1.58

0.741

≥26

0.095

1.10

0.77–1.57

0.605

  1. The missing values were estimated using the multiple imputation method.